Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - MERIDIAN BIOSCIENCE INC | d24550dex312.htm |
| EX-31.1 - EX-31.1 - MERIDIAN BIOSCIENCE INC | d24550dex311.htm |
| EX-23 - EX-23 - MERIDIAN BIOSCIENCE INC | d24550dex23.htm |
| EX-21 - EX-21 - MERIDIAN BIOSCIENCE INC | d24550dex21.htm |
| EX-10.16 - EX-10.16 - MERIDIAN BIOSCIENCE INC | d24550dex1016.htm |
| EX-10.8 - EX-10.8 - MERIDIAN BIOSCIENCE INC | d24550dex108.htm |
| EX-10.7 - EX-10.7 - MERIDIAN BIOSCIENCE INC | d24550dex107.htm |
| EX-10.6 - EX-10.6 - MERIDIAN BIOSCIENCE INC | d24550dex106.htm |
| 10-K - 10-K - MERIDIAN BIOSCIENCE INC | d24550d10k.htm |
Exhibit 32
Certification of Chief Executive Officer and Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing with the Securities and Exchange Commission of the Annual Report of Meridian Bioscience, Inc. (the “Company”) on Form 10-K for the period ended September 30, 2020 (the “Report”), the undersigned officers of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| /s/ Jack Kenny |
| Jack Kenny |
| Chief Executive Officer |
| November 23, 2020 |
| /s/ Bryan T. Baldasare |
| Bryan T. Baldasare |
| Executive Vice President and |
| Chief Financial Officer |
| November 23, 2020 |